2 completed. 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Completed 2 |
Follow DA-9801: new trials by email Literature Review of DA-9801 trials Research Report on DA-9801
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study of DA-9801 to Treat Diabetic Neuropathy DA-9801 300mg, DA-9801 600mg, DA-9801 900mg - Diabetic Neuropathy | Phase 2 | Completed | NeuroBo Pharmaceuticals Inc. | 128 | 2013-11-01 | 2020-03-20 |
| Study of DA-9801 to Treat Diabetic Neuropathic Pain DA-9801 300mg, DA-9801 600mg, DA-9801 900mg - Diabetic Neuropathies | Phase 2 | Completed | Dong-A ST Co., Ltd. | 128 | 2011-11-01 | 2019-04-16 |
Diabetic Neuropathies (2) · Diabetes Mellitus (1) · Pain (1)
Dong-A ST Co., Ltd. (1) · NeuroBo Pharmaceuticals Inc. (1)
South Korea (1) · United States (1)
Bongyeon Cha, M.D. (1) · Chong Hwa Kim, M.D. (1) · Chun Hee Jung, M.D. (1) · Dong Hyeok Cho, M.D. (1) · Gabriel Maislos, D.P.M (1) · Hyeok Sang Gwon, M.D. (1) · In Ju Kim, M.D. (1) · Inkyung Jeong, M.D. (1) · Jeong Guk Kim, M.D. (1) · Ji Hyeon Lee, M.D. (1) · Jyeong Hyeon Park, M.D. (1) · Kwan Pyo Ko, M.D. (1) · Min Kyong Moon, M.D. (1) · Mun Seok Nam, M.D. (1) · Young Min Cho, M.D. (1)